CRT patterns and short-term outcomes on unresectable NSCLC in routine practices in Russia

Trial Identifier:	D133HR00026
Sponsor:	AstraZeneca
Start Date:	March 2023
Primary Completion Date:	December 2025
Study Completion Date:	December 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Grozny, Russia
Russia	Irkutsk, Russia
Russia	Kostroma, Russia
Russia	Sochi, Russia
Russia	Yuzhno-Sakhalinsk, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.